Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-10-31T10:07:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces the transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to related updates and FAQs.
    Difference
    0.3%
    Check dated 2026-10-24T11:07:36.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-17T11:34:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-10T12:37:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry (v3.7.0). The previous revision (v3.6.6) is removed, updating the version history of the study record.
    Difference
    0.0%
    Check dated 2026-09-19T18:40:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.6 on the Record History page, replacing the previous v3.6.5. This appears to be an update to the site version rather than a change to the trial data or visible content.
    Difference
    0.0%
    Check dated 2026-08-29T19:54:26.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.